Millendo is working to ease the burden of patients with severe endocrine diseases
Millendo is leveraging novel biological insights to advance a portfolio of endocrine therapeutics
Millendo is restoring hormonal balance to patients with endocrine diseases
May 15, 2019Millendo Therapeutics Reports First Quarter 2019 Operating and Financial Results
May 8, 2019Millendo Therapeutics Announces 21st European Congress of Endocrinology 2019 Presentations on Livoletide for Prader-Willi Syndrome and Nevanimibe for Classical Congenital Adrenal Hyperplasia
